GN Store Nord A/S (CPH:GN)
96.28
+0.16 (0.17%)
Aug 28, 2026, 4:59 PM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 14.02 billion as of August 28, 2026. Its market cap has decreased by -17.00% in one year.
Market Cap
14.02B
Enterprise Value
23.76B
Revenue
16.46B
Ranking
n/a
PE Ratio
78.37
Stock Price
96.28
ChartMarket Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 14.02B, an increase of 4,146.49%. That is a compound annual growth rate of 11.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 14.02B | -9.81% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 128.72B |
| Coloplast | 104.19B |
| Demant | 60.19B |
| H. Lundbeck | 40.98B |
| Zealand Pharma | 21.31B |
| Ambu A/S | 18.60B |
| Bavarian Nordic | 16.15B |